CLAZF   $0.04  -42.86% Market Open


Current temperature:
ST: None, Cor:

ISIN CA1806342061
ceo Mr. Robert Farrell J.D.
Website https://claritaspharma.com
Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. Claritas Pharmaceuticals, Inc. was founded in 2014 and is based in San Rafael, California.